# Anna Mazo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/anna-mazo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 139 |
| Field | Cardiac pacing and defibrillation studies |
| h-index | 4 |
| i10-index | 4 |
| Last Known Institution | Boehringer Ingelheim (Germany) |
| OpenAlex ID | https://openalex.org/A5023462423 |
| Works | 12 |

## Researcher papers

- [Regional Antibiotic Delivery for Implanted Cardiovascular Electronic Device Infections](https://scholariq.org/papers/regional-antibiotic-delivery-for-implanted-cardiovascular-electronic-device/)
- [Effect of pacemaker implantation after transcatheter aortic valve replacement on long- and mid-term mortality](https://scholariq.org/papers/effect-of-pacemaker-implantation-after-transcatheter-aortic-valve-replacement-on/)
- [Chewing versus Swallowing Ticagrelor to Accelerate Platelet Inhibition in Acute Coronary Syndrome - the CHEERS study](https://scholariq.org/papers/chewing-versus-swallowing-ticagrelor-to-accelerate-platelet-inhibition-in-acute/)
- [Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy](https://scholariq.org/papers/super-response-to-cardiac-resynchronization-therapy-reduces-appropriate/)
- [Arrhythmic Events in Brugada Syndrome: A Nationwide Israeli Survey of the Clinical Characteristics, Treatment; and Long-Term Follow-up (ISRABRU-VF).](https://scholariq.org/papers/arrhythmic-events-in-brugada-syndrome-a-nationwide-israeli-survey-of-the/)
- [Empagliflozin Reduces Risk of Hospitalization in Patients With Chronic Kidney Disease in the EMPA-KIDNEY Trial](https://scholariq.org/papers/empagliflozin-reduces-risk-of-hospitalization-in-patients-with-chronic-kidney/)
- [Effect of empagliflozin on all-cause hospitalization in EMPA-KIDNEY](https://scholariq.org/papers/effect-of-empagliflozin-on-all-cause-hospitalization-in-empa-kidney/)
- [Abstract 16351: Arrhythmic Events in Brugada Syndrome: A Nation-Wide Israeli Survey of the Clinical Characteristics, Treatment and Long-Term Follow-Up (ISRABRU-VF)](https://scholariq.org/papers/abstract-16351-arrhythmic-events-in-brugada-syndrome-a-nation-wide-israeli/)
- [PO-02-086 A NOVEL ANTIBIOTIC DELIVERY APPROACH FOR SALVAGE OF CARDIOVASCULAR-IMPLANTABLE ELECTRONIC DEVICES WITH LOCALIZED INFECTION](https://scholariq.org/papers/po-02-086-a-novel-antibiotic-delivery-approach-for-salvage-of-cardiovascular/)
- [Budget Impact Analysis for Empagliflozin in Patients with Nondiabetic CKD](https://scholariq.org/papers/budget-impact-analysis-for-empagliflozin-in-patients-with-nondiabetic-ckd/)

## Researcher topics

- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Researcher university

- [Boehringer Ingelheim (Germany)](https://scholariq.org/institutions/boehringer-ingelheim-germany/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.